OrthoVentions (OV) is the premier accelerator fund for musculoskeletal innovation in partnership with the premier musculoskeletal surgeon group at the Hospital for Special Surgery (HSS). Through our partnership with HSS, we are accelerating the development of concepts into market-ready solutions. Join us in shaping the future of commercializing musculoskeletal innovations.
At OrthoVentions, we collaborate directly with top surgeons from HSS to pioneer new technologies. Grounded in clinical expertise and the latest musculoskeletal advancements, our solutions address real-world needs.
We set the bar high. Our selection process is competitive, driven by market-focused criteria. Only the most impactful innovations earn our support, vetted by Key Opinion Leaders and industry experts to ensure alignment with market demands.
Success hinges on teamwork. OrthoVentions boasts a seasoned team with a track record in product development and commercialization. With access to talent in product development, regulatory/quality affairs, and healthcare economics, we efficiently turn ideas into market-ready products, maximizing the potential of each project.
Combined with a rigorous review and commercial fitness assessment through socializing technologies with strategic partners, OrthoVentions concentrates on achievable FDA regulatory pathways and limited market release value creation — an optimal period that maximizes velocity for capital return.
Combined with a rigorous review and commercial fitness assessment through socializing technologies with strategic partners, OrthoVentions concentrates on achievable FDA regulatory pathways and limited market release value creation — an optimal period that maximizes velocity for capital return.
The partnership's flagship pipeline company, GeminiOV, is now under the FDA approval process with more in advanced development.
Revolutionizing musculoskeletal imaging with digital twin technology, providing scope-less views of joint integrity and driving informed surgical decisions.
An integrated implant and single-use instrument solution addressing arthritis of the toe through a novel 3D printed anatomic design to maintain stability, preserve motion and reduce pain for the patient.
The partnership's flagship pipeline company, GeminiOV, is now under the FDA approval process with more in advanced development.
Revolutionizing musculoskeletal imaging with digital twin technology, providing scope-less views of joint integrity and driving informed surgical decisions.
An integrated implant and single-use instrument solution addressing arthritis of the toe through a novel 3D printed anatomic design to maintain stability, preserve motion and reduce pain for the patient.
At OrthoVentions, we are dedicated to revolutionizing the musculoskeletal healthcare landscape. With a wealth of experience and expertise spanning diverse domains, our operators are at the forefront of innovation in orthopedic technology.
Managing Director & Co-Founder
20+ years of Healthcare Executive & Investment Experience
Managing Director & Co-Founder
25+ years of Healthcare Investment Experience
Managing Director & Co-Founder
20+ years of Healthcare Executive & Investment Experience
Managing Director & Co-Founder
25+ years of Healthcare Investment Experience
After a tremendously successful initial partnership on our first OrthoVentions investment—GeminiOV—we have formalized an overarching strategic partnership with Thinktiv, the leading value creation services firm for emerging technology product businesses.
OrthoVentions and Thinktiv merge 50+ years of expertise in life-science tech and commercialization, forging a powerhouse team of industry leaders, clinical champions, and healthcare strategists dedicated to bringing transformative healthcare solutions to market. With a track record of strategic exits and unmatched proficiency in clinical, medical device, and life sciences, our investment leaders are primed to lead healthcare innovation.
At OrthoVentions, we are dedicated to revolutionizing the musculoskeletal healthcare landscape. With a wealth of experience and expertise spanning diverse domains, our operators are at the forefront of innovation in orthopedic technology.
Managing Director & Co-Founder
Managing Director & Co-Founder
After a tremendously successful initial partnership on our first OrthoVentions investment—GeminiOV—we have formalized an overarching strategic partnership with Thinktiv, the leading value creation services firm for emerging technology product businesses.
OrthoVentions and Thinktiv merge 50+ years of expertise in life-science tech and commercialization, forging a powerhouse team of industry leaders, clinical champions, and healthcare strategists dedicated to bringing transformative healthcare solutions to market. With a track record of strategic exits and unmatched proficiency in clinical, medical device, and life sciences, our investment leaders are primed to lead healthcare innovation.
Discover our pipeline of cutting-edge innovations, each poised to enhance your platform and deliver solutions that set new industry standards.
Ready to take the next step with your innovative idea? Submit your invention disclosure today and start your journey towards transforming healthcare with OrthoVentions.
Discover our pipeline of cutting-edge innovations, each poised to enhance your platform and deliver solutions that set new industry standards.
Ready to take the next step with your innovative idea? Submit your invention disclosure today and start your journey towards transforming healthcare with OrthoVentions.